Journal of Controlled Release Cover Letter
A Journal of Controlled Release cover-letter template for the required one-paragraph originality and significance explanation.
Readiness scan
Before you submit to Journal of Controlled Release, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Journal of Controlled Release at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- Journal of Controlled Release's scope and readership determine whether the journal is a useful target.
- Scope specificity matters more than headline metrics for most manuscript decisions.
- Selectivity at this journal means fit and framing determine most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
- If timeline matters: Journal of Controlled Release takes Editorial screening first. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Getting the structure, tone, and decision logic right before you send anything out. |
Most important move | Make the reviewer-facing or editor-facing ask obvious early rather than burying it in prose. |
Common mistake | Turning a practical page into a long explanation instead of a working template or checklist. |
Next step | Use the page as a tool, then adjust it to the exact manuscript and journal situation. |
Quick answer: A Journal of Controlled Release cover letter must explain the originality and significance of the submitted work in one paragraph. The current Guide for Authors says the manuscript will not be processed without this information. For a Review, the letter is only one part of the route: upload a separate five-section Review Proposal in Editorial Manager as well.
The official Journal of Controlled Release Guide for Authors defines the letter and Review Proposal requirements. Use the Journal of Controlled Release submission guide for delivery-science fit, files, declarations, and the broader submission decision, or the JCR journal route for journal context.
Check your Journal of Controlled Release cover-letter fit before upload.
Use this page before submitting to make the required paragraph and any Review Proposal agree with the evidence in the manuscript package.
What JCR requires in the Letter of Submission
Requirement | What to do in the letter |
|---|---|
One paragraph on originality and significance | State the delivery-science question, evidence-supported advance, and why the difference matters against an appropriate current standard. |
Submission declaration | Keep the letter consistent with the record that the work is not under consideration elsewhere and is approved by all authors. |
Review route | Upload the separate Review Proposal file in addition to the cover letter. |
Formal declarations | Use the declarations tool for competing interests; do not use a letter sentence as a replacement. |
Preprint context | A permitted preprint is not prior publication, but do not misdescribe the record. |
JCR is the official journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Its guide says manuscripts that improve fundamental understanding or demonstrate safety and efficacy advantages over current clinical standards receive priority. A strong paragraph therefore does more than call a carrier or formulation “novel”: it identifies the release, delivery, biological, or translational claim and the evidence that distinguishes it from a nearby alternative.
How this page was researched: the live guide's Journal-specific information, article-type, ethics, declarations, preprint, and submission sections were compared with the existing JCR submission guide. This page owns the required one-paragraph letter and review-proposal boundary; the existing guide remains owner for delivery fit, manuscript package, and portal workflow.
Copyable Journal of Controlled Release cover-letter template
Dear Journal of Controlled Release Editors,
Please consider our [MANUSCRIPT TYPE], "[MANUSCRIPT TITLE]," for Journal of
Controlled Release. This work addresses [DELIVERY OR RELEASE PROBLEM] by
[MECHANISM, DESIGN, OR STRATEGY]. Its originality is [DIFFERENCE FROM A
CURRENT DELIVERY APPROACH OR CLINICAL STANDARD]. Its significance is
supported by [KEY RELEASE, PHARMACOKINETIC, BIODISTRIBUTION, BIOLOGICAL,
SAFETY, OR EFFICACY EVIDENCE], which shows [BOUNDED CONSEQUENCE FOR DELIVERY
SCIENCE OR USE].
This manuscript has not been published and is not under consideration
elsewhere. All authors have approved the submission. [FOR A REVIEW: the
separate Review Proposal file is uploaded in Editorial Manager.]
Sincerely,
[CORRESPONDING AUTHOR CONTACT]The JCR-specific originality-and-significance paragraph
Weak: We report a novel nanoparticle platform with excellent drug-delivery potential.
Stronger: We show that charge-switching in a polymer depot controls release after exposure to the colonic redox environment, and that matched neutral-polymer controls, in vivo exposure, and inflammation readouts separate the mechanism from nonspecific retention. The result offers a defined route to prolonged local exposure while limiting systemic concentration in this disease model.
The stronger version identifies the delivery problem, the causal design feature, the evidence that discriminates the explanation, and the boundary of the significance claim. It does not convert a loading result, a particle image, or one in-vitro curve into a clinical assertion.
In our pre-submission review work with Journal of Controlled Release-targeted manuscripts: common failure patterns
Across drug-delivery packages, the letter often names a material class and a therapeutic aspiration but leaves the originality and significance paragraph unable to show what has actually changed. JCR's guide makes that paragraph a processing condition. It should allow an editor to see the delivery-science contribution before relying on a title, abstract, or a long list of assays.
Originality is a new formulation, not a new delivery insight.
A new polymer, lipid ratio, particle size, loading protocol, or surface chemistry is not by itself the originality argument. State the release-control, biological-barrier, localization, exposure, safety, or efficacy problem it changes. Then name the comparator and the experiment that separates the proposed mechanism from an expected formulation effect.
Significance is claimed from in-vitro performance alone.
Cell viability, uptake, loading, morphology, and release curves can matter, but they do not always establish therapeutic, pharmacokinetic, biodistribution, or safety significance. Keep the letter's consequence proportional to the model and evidence. If the paper is in-vitro only, explain the delivery mechanism and narrow the claim instead of implying clinical readiness.
The nearest standard is never named.
The current guide says priority goes to work demonstrating advantages in safety and efficacy over current clinical standards. If a clinical standard is relevant, name it and explain the comparison. If the work is earlier-stage, name the nearer scientific or technological comparator and do not pretend that a laboratory benchmark is a clinical advantage.
A Review uses the research-article letter alone.
For review articles, the official route requires a separate Review Proposal in addition to the Cover Letter. A persuasive one-paragraph letter cannot replace the five requested proposal sections on relevance, originality and timeliness, expertise, five representative topic publications, and five best publications.
Declarations are duplicated inconsistently.
JCR requires authors to complete the declarations tool and upload its Word document. Do not place a simplified competing-interest claim in the letter that conflicts with the formal document, author roles, funding statement, title page, or Editorial Manager fields.
The editorial question is whether the stated advance can be traced to a delivery-relevant mechanism and evidence. A short paragraph is effective when it makes that chain visible. A generic “important nanomedicine” sentence creates a burden for the editor to reconstruct it.
JCR Review Proposal: the separate five-part file
The journal encourages review proposals. If authors have already written the review, the guide says to submit the manuscript in Editorial Manager together with the requested Review Proposal form. Keep this file separate from the letter and make each section concrete.
Review Proposal section | Decision it supports |
|---|---|
Why this topic? | Relevance to JCR readers, drug-delivery science, and beyond. |
What is new, and why now? | Originality and timeliness of the review rather than the topic's general importance. |
Why you? | Author expertise and track record. |
Five representative publications | Direct topic-relevant publication record. |
Five best publications | Author record in drug-delivery science or more generally. |
The guide also asks authors to ensure recommendations comply with competing-interest and publishing-ethics standards and to consider inclusion and diversity. Do not manufacture a publication record, list unrelated high-citation papers, or frame a broad literature summary as an urgent review without defining the gap it resolves.
Submission context that must agree with the letter
Package item | Check before submit |
|---|---|
Originality/significance paragraph | Names the same delivery claim and evidence as title, abstract, and figures. |
Submission declaration | Matches the manuscript's publication and concurrent-submission status. |
Author approvals | All authors approve; author list matches the portal and manuscript. |
Competing interests | Declarations tool output is uploaded as the required Word document. |
Generative-AI disclosure | If applicable, put the requested statement in the manuscript before references, not in a substitute letter sentence. |
Preprint | Describe it accurately; permitted sharing is not prior publication. |
The guide requires editable source files for the submission and says a PDF alone is not an acceptable source file. It also allows references in any consistent style at initial submission and applies house style after acceptance. Those mechanics do not belong in the originality paragraph; use the letter for the required scientific rationale and use the files and portal fields for their own declared jobs.
JCR limits the abstract to 250 words. Use that limit to state purpose, principal results, and conclusions concisely; use the required letter paragraph to make the editor-facing originality and significance case without repeating the abstract.
Submit if
- one paragraph names a delivery or release problem, the supported advance, and why it matters
- the central claim has a real comparator and evidence appropriate to the consequence claimed
- the letter, abstract, title, figures, data record, and declarations describe the same level of certainty
- Review submissions include the separate five-section Review Proposal
- all authors, publication status, conflicts, funding, and preprint facts are represented consistently
Readiness check
Run the scan while Journal of Controlled Release's requirements are in front of you.
See how this manuscript scores against Journal of Controlled Release's requirements before you submit.
Think twice if
- the paragraph could accompany a materials paper with no reference to release, delivery, exposure, or biological barrier
- “significance” means only a higher loading number, faster uptake, or a better single benchmark
- a therapeutic or clinical claim rests only on in-vitro data without a stated limit
- a Review Proposal substitutes generic author biographies for the five required publication sections
- the formal declarations would reveal a relationship or status missing from the letter
A practical last pass
Read the title, abstract, first figure, and one-paragraph letter in sequence. Each should state the same delivery problem and make the same bounded claim. Then compare the letter with the submission declaration, author approvals, declarations-tool Word document, funding disclosure, data statement, and preprint record. If the comparison or evidence is not ready, change the claim or the journal route rather than expanding the letter into a second abstract.
For a review, perform a second pass on the five-part Review Proposal. It should be a proposal for this review in this journal, not a recycled cover letter. The relevance, timing, author expertise, and publication lists are separate editorial decisions, so give each one its own evidence.
Frequently asked questions
Yes. The current Guide for Authors says the Letter of Submission must explain the originality and significance of the work in one paragraph, and that the manuscript will not be processed without that information.
Give one evidence-based paragraph explaining originality and significance, then make sure it agrees with the submission declaration, author approvals, competing-interest record, and the manuscript's delivery-science evidence.
No. The current guide asks review authors to upload a separate Review Proposal file in Editorial Manager in addition to the Cover Letter. That file has five specified sections.
Address relevance to JCR readership and drug-delivery science, originality and timeliness, author expertise, five representative topic publications, and five best author publications in drug-delivery science or general.
Yes. The current guide says sharing a preprint in line with Elsevier policy does not count as prior publication.
Use the declarations tool and upload its resulting Word document as required. Keep any cover-letter disclosure consistent with that formal record rather than treating the letter as a substitute.
Sources
Final step
Submitting to Journal of Controlled Release?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: Journal of Controlled Release
Anthropic Privacy Partner. Your manuscript is never used to train any model.